{'fraction_non_alphanumeric': 0.06648451730418943, 'fraction_numerical': 0.06329690346083788, 'mean_word_length': 4.319612590799031, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 4, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Reliability of Single‐Lead VDD Atrial Sensing and Pacing During Exercise

If atrial sensing ability of a single‐lead VDD pacemaker is well accepted at rest, the detection quality by atrial floating electrodes remains less recognized during exercise. The aim of this study was to verify, during tread‐mill test and a continous telemetry, the atrial tracking performance using four different leads technologies. From November 1994 to July 1997, 21 patients (71.3 ± 6.3 years old. 7 female, cardiopathy: 57%) were paced for isolated high degree (permanent: 13, paroxystic: 8) AV block. The implanted devices were the Vitatron Saphir/Brillant lead (13 patients), Intermedics Unity/425/04–13 lead (5 patients), Pacesetter Addvent (2 patients), and Biotronik Eikos (1 patient). The acute atrial signal amplitude was 1.66 ± 0.75 mV. The treadmill test used the chronotropic assessment exercise protocol after pacemaker reprogramming to detect atrial undersensing (AV delay ≤ 120 ms, no hysteresis, no flywheel, upper rate increase). The mean delay was 31.1 weeks (range 1–100). The testing duration was 6.1 ± 2.3 minutes, the number of steps was 3.3 ± 1.3 per patient, and the peak exercise rate was 135 ± 19 beats/min. At rest, complete atrial tracking was complete in 90% of the patients, and during testing in only 23.8% of the patients, while AV synchronization > 95% was present in 57.1%, > 90% in 71.4%, and > 85% in 90.4% of patients (Vitatron 13/13, Intermedics 3/5, Biotronik 1/1, and Pacesetter 1/2). During the recovery period synchronization was always > 95%. The mean P wave amplitude at rest was 1.1 ± 0.5 mV; during the first step, 1.04 ± 0.61 mV; second step, 0.94 ± 0.53 mV; third step, 0.82 ± 0.58 mV; fourth step, 0.67 ± 0.39 mV; and during recovery, 1.13 ± 0.67 mV. The mean P wave decrease signal at peak of exercise is 0.21 mV (from ‐1.31 to +0.5). In fact, P wave variations have several patterns: a decrease was measured in 7 patients, an increase in 2 patients, and no significant change in 7 patients. Single‐lead VDD P wave identification during exercise was almost accurate. However, often there was progressive lowering of atrial sensing with transient loss of AV synchrony.